Ministry of Health, France

• Phase I/II Trial of Dinutuximab Beta in Combination With Irinotecan and Rapamycin in Pediatric, Adolescents and Adult Patients With Relapsed/Refractory Bone Tumors.

  Collaborator, Phase 1/2, Not yet recruiting, 89 people, 1 Oct 2026

• Therapeutic Effect of Hydroxychloroquine on Immunoglobulin A (IgA) Nephropathy Course QUIgAN Study

  Collaborator, Phase 2, Recruiting, 334 people, 5 Apr 2024

• Effects of Local Vibrations Program of Dorsiflexor Muscles on Neuromotor Recovery in Subacute Stroke Patients.

  Collaborator, Recruiting, 70 people, 14 Jul 2023

• NCT05946564

  Collaborator, Phase 3, Recruiting, 126 people, 14 Jul 2023

• NCT05476939

  Collaborator, Phase 3, Recruiting, 433 people, 27 Jul 2022

• NCT05114278

  Collaborator, Phase 4, Terminated, 1 person, 9 Nov 2021

• NCT04935684

  Collaborator, Phase 2, Recruiting, 150 people, 23 Jun 2021

• NCT04581447

  Collaborator, Phase 3, Recruiting, 126 people, 9 Oct 2020

• NCT03551548

  Collaborator, Phase 3, Status unknown, 1,500 people, 11 Jun 2018

• NCT03293069

  Collaborator, Phase 2/3, Completed, 372 people, 26 Sept 2017

• NCT03249844

  Collaborator, Phase 3, Withdrawn, 0 people, 15 Aug 2017

• NCT03243175

  Collaborator, Phase 3, Recruiting, 300 people, 8 Aug 2017

• NCT03243019

  Collaborator, Phase 2, Recruiting, 28 people, 8 Aug 2017

• NCT03083184

  Collaborator, Phase 3, Recruiting, 400 people, 17 Mar 2017

• NCT03033823

  Collaborator, Phase 3, Completed, 105 people, 27 Jan 2017

• NCT02892916

  Collaborator, Phase 3, Completed, 307 people, 8 Sept 2016

• NCT02824718

  Collaborator, Phase 2, Completed, 16 people, 7 Jul 2016

• NCT02664155

  Collaborator, Phase 3, Terminated, 203 people, 26 Jan 2016

• NCT02359513

  Collaborator, Phase 4, Completed, 51 people, 10 Feb 2015

• NCT02281929

  Collaborator, Phase 3, Completed, 297 people, 4 Nov 2014

Sources: clinicaltrials.gov